Invention Grant
- Patent Title: Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients
-
Application No.: US16614582Application Date: 2018-05-21
-
Publication No.: US11459382B2Publication Date: 2022-10-04
- Inventor: Orly Eshach Adiv , Camille Bedrosian , Hagit Baris Feldman , Alina Kurolap , Susan Faas McKnight
- Applicant: Alexion Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jill Gorny Sloper, Esq.
- International Application: PCT/US2018/033678 WO 20180521
- International Announcement: WO2018/217638 WO 20181129
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61P1/00 ; A61K39/00
Abstract:
Provided are methods for clinical treatment of a protein-losing enteropathy, such as lymphangiectasia, using an anti-C5 antibody, or antigen binding fragment thereof, in patients (e.g., pediatric patients).
Public/Granted literature
- US20200172603A1 DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS Public/Granted day:2020-06-04
Information query
